Laxmi Dental LimitedPharmaceuticals & HealthcareLAXMIDENTL
Q1 FY27 concall · earnings callLaxmi Dental Limited
Laxmi Dental achieved its highest-ever quarterly revenue and profitability, driven by strong growth across its dental lab and aligner solutions businesses.
Numbers
| Metric | This quarter | Change | Five-quarter trend |
|---|---|---|---|
| Revenue | ₹74.7 Cr | 13.9% | |
| EBITDA | ₹14.4 Cr | 20.6% | |
| EBITDA Margin | 19.2% | — | |
| PAT | ₹10.3 Cr | 23.8% | |
| PAT Margin | 13.8% | — | |
| Dental Lab Growth y-o-y | 23.5% | — | |
| International Business Growth y-o-y | 37.4% | — | |
| Aligner Business Growth y-o-y | 28.6% | — |
TL;DR
- Revenue was INR74.7 crores, a 13.9% y-o-y growth, marking the highest-ever quarterly revenue.
- EBITDA grew 20.6% y-o-y to INR14.4 crores with margin improving to 19.2%; PAT grew 23.8% to INR10.3 crores.
- Dental lab business grew 23.5% y-o-y, with international growth at 37.4%.
- Aligner business grew 28.6% y-o-y, with Kids-e-Dental segment up 54.4%.
- Planned investment in new machinery and acquisition of land in Palghar for a new owned facility.
- Scanner deployment target for FY27 is 800 to 1,000 units, with average price around INR3 lakhs.
Said on the call
“This was our highest ever quarterly revenue.”
From the Q&A
| Topic | What management said |
|---|---|
| Customer Differentiation | Management cited 36 years of trust, global quality standards, and being the only branded player in the crown category as key reasons dentists choose Laxmi Dental. |
| Scanner Margins & Strategy | Scanners have a trading margin of 15% to 20%, causing minor fluctuations; excluding scanners, margins are stable and rising. The target is to deploy 800 to 1,000 scanners in FY27 at an average price of INR3 lakhs. |
| Capacity Utilization | Aligner capacity utilization is around 70%, while lab capacity is at a constant threshold of 90%-95% due to its custom nature. |
| New Land Acquisition | The land in Palghar is for transitioning from leased facilities to an owned one to improve workflow efficiency, control costs, and support future scalability; no disruption is expected during the move. |
| Domestic Lab Growth Outlook | Domestic lab growth was 12% y-o-y; management expects growth to accelerate in coming quarters due to scanner deployment maturity and satellite labs. |
| AI-Led Automation Expenses | Higher other expenses were partly due to initial AI-related costs for beta models, but these are expected to reduce as the company scales. |
| Aligner Business Strategy | The company sells only through dentists (B2B), not directly to patients (B2C), and does not segregate between orthodontists and general dentists. |
Guidance
- Aspiration for revenue growth is 15% to 20%.
- Aspiration for EBITDA margin is 18% to 20%.
- Plan to deploy 800 to 1,000 scanners in FY27.
- Investments planned in new machinery and a new owned facility in Palghar to modernize and expand capacity.
Source
Summary written from the transcript filed by Laxmi Dental Limited for the call held on 12 Aug 2026; published 19 Aug 2026, 16:35 IST.
More Q1 FY27 concalls ·How verification works ·Report an error